The Ras/cAMP pathway and the CDK-like kinase Ime2 regulate the MAPK Smk1 and spore morphogenesis in Saccharomyces

Christine M McDonald1, Marisa Wagner, Maitreya J Dunham

  • 1Department of Genome Science, University of Washington, Seattle, Washington 98195, USA.

Genetics
|December 18, 2008
PubMed

Insights

Nutritional deprivation impacts yeast sporulation by regulating the Smk1 MAP kinase. Researchers identified key genes in the Ras/cAMP pathway and the Ime2 kinase that control Smk1 activation during this crucial developmental process.

Area of Science:

  • Cellular biology
  • Molecular genetics
  • Yeast research

Background:

  • Meiotic development in Saccharomyces cerevisiae (yeast) is triggered by nutrient scarcity.
  • Smk1, a meiosis-specific MAP kinase, is essential for spore formation post-meiosis.
  • Understanding Smk1 regulation is key to deciphering yeast sporulation.

Purpose of the Study:

  • To identify genetic factors that suppress defects in Smk1-mediated sporulation.
  • To elucidate the regulatory mechanisms controlling Smk1 activity during meiosis.
  • To investigate the interplay between nutrient signaling and meiotic development.

Main Methods:

  • Isolation and characterization of recessive suppressors of a smk1-2 temperature-sensitive mutant.
  • Genetic analysis of CDC25, CYR1, MDS3, and PMD1 genes involved in Ras/cAMP signaling.
  • Examination of the role of Ime2, a meiosis-specific kinase, in Smk1 activation.

Main Results:

  • Mutations in CDC25, CYR1, MDS3, and PMD1 partially suppress smk1-2 sporulation defects.
  • The Ras/cAMP pathway and its regulators MDS3/PMD1 influence Smk1 function, particularly under low glucose conditions.
  • Ime2 kinase activity is required for Smk1 activation and is negatively regulated by glucose levels.

Conclusions:

  • Nutrient availability, mediated by the Ras/cAMP pathway, negatively regulates Smk1 activity.
  • Ime2 acts as a crucial upstream activator of Smk1 signaling during yeast meiosis.
  • This study reveals a novel nutrient-sensitive regulatory axis controlling meiotic development in yeast.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...